skygaming777
MUPPETS’ Christmas Carol fans are only just realising one Inbetweeners star appeared in the classic movie. Robin Weaver, 43, best known for her role as Simon’s mum, Pamela Cooper, in the Channel 4 comedy , played Clara, Fred’s wife, in the 1992 festive film . For years, the playful retelling of Charles Dickens’ timeless tale has been a staple of the holiday season. Featuring the Muppets cast and Michael Caine ’s performance as Scrooge, the new discovery has given fans a whole new reason to rewatch the movie this Christmas . The revelation gained traction after a Reddit user posted in a forum titled, "Approaching my 35th Christmas, and I've only just realised that Clara (Fred's wife) in Muppet Christmas Carol is Simon's mum in the Inbetweeners ." The post quickly drew reactions from fans thrilled to connect the dots between the two roles. more on the Inbetweeners One user exclaimed, “I live for these facts,” while another added, “Thank you! I watched it this week and was desperately trying to work out what I knew her from!” A third joked, “Bloody hell, Simon’s older than he looks,” adding some Inbetweeners humor into the conversation. But Robin isn’t the only cast member in The Muppets’ Christmas Carol with ties to other iconic works. Steven Mackintosh, who plays Fred (Scrooge’s jovial nephew and Clara’s husband), is known for his role in Lock, Stock and Two Smoking Barrels. Most read in Film Someone pointed this out on the site, writing: "And Fred is that bloke from Lock Stock!" When it was first released in 1992, many thought the Disney film was going to be a huge flop. Pairing a much-loved Charles Dickens novel with a load of puppets and actor Sir Michael didn’t seem like a recipe for success. On top of that, The Muppets had lost two of its most prominent figureheads - Muppets creator Jim Henson, who died suddenly in May 1990, followed by puppeteer Richard Hunt in January 1992. But 32 years later, it’s become a festive classic, watched by kids over and over every year.LOS ANGELES — Considering how their seasons have ebbed and flowed so far, and the history between the stars leading their teams, it’s only appropriate that the Lakers and Golden State Warriors match up for a Christmas Day showdown on Wednesday at Chase Center. Just a month ago, the Lakers and Warriors were sitting near the top of the Western Conference standings, opening the season with 10-5 and 12-3 records, respectively, entering Nov. 23. How much a month can change things. The Lakers (16-13) have gone 6-8 since then after dropping Monday’s home game to the Detroit Pistons to end their three-game winning streak. And the Warriors (15-13) have been even worse, winning just three of their last 13 games after starting the year at the top of the conference. But Wednesday will be another matchup between Lakers star LeBron James and Warriors star Steph Curry – two all-time greats whose careers have intersected to the point they’re considered by many to have one of the defining rivalries of the league’s modern era. “Anytime you get an opportunity to be on the court and compete versus one of the greats to ever play this game, you never take it for granted,” James said. “I don’t know how many more opportunities we’re gonna get to go against each other, so it’s always fun.” Wednesday will also mark the second time the Lakers and Warriors have played each other on Christmas in the past seven years, with the Lakers beating the Warriors on Dec. 25, 2018, in James’ first season with the Lakers. In addition to the 2018 matchup , James’ and Curry’s teams squared off on Christmas for three consecutive seasons (2015-17) when James was on the Cleveland Cavaliers. Curry didn’t play in the 2017 game. But matchups between James and Curry have historically had more at stake than Christmas Day game bragging rights. Their teams matched up in four consecutive NBA Finals (2015-18), with Curry’s Warriors winning the championship in 2015, ‘17 and ‘18 and James’ Cavaliers coming out on top in ’16 after coming back from a 3-1 series. “For me, as a fan, it was an awesome stretch,” Lakers coach JJ Redick said. “For me as a player, it wasn’t a great stretch because I wasn’t in those Finals. But it was great to have two of the icons of this generation go head to head and have some for sure classic series and then just also some classic games and classic moments. “Throughout the history of the NBA, player and team rivalries have been good for the league and that sort of captured a moment in our generation.” The Lakers and Warriors also played each other in the 2021 Play-In Tournament and the second round of the 2023 playoffs, with the Lakers winning both matchups “It’s going to be good,” Anthony Davis said. “We always have battles with them, we’ve seen them in the playoffs a couple of years. It’s going to be fun to go up to The Bay and try to get a win on Christmas Day.” Not including the Play-In Tournament game, Wednesday will mark the 53rd matchup between a team led by James and Curry. Curry’s teams have a 29-23 record in those matchups, including a 17-11 record in the playoffs. But the relationship between James, who’s in his 22nd NBA season and will return 40 on Monday, and Curry, who’s in his 16th NBA season and will turn 37 in March, has evolved over the years since consistently playing against one another in the Finals. James and Curry teamed up this past summer, leading Team USA to a gold medal in the Paris Olympics. “It’s a fun battle because of the longevity of how long we’ve been doing this,” Curry said during an appearance on ESPN’s “NBA Today” on Tuesday. “There’s more appreciation and respect than probably back in the day because there was a lot of pettiness and resentment. The rivalry was real but it evolves and you still want to go at each other, but the respect is there.” When : Wednesday, 5 p.m. Where : Chase Center, San Francisco TV/radio : ABC/ESPN, 710 AM
EU’s Borrell calls for pressure on Israel, Hezbollah to accept cease-fire
NEW YORK and LONDON , Dec. 12, 2024 /PRNewswire/ -- Pearl Diver Credit Company Inc. (NYSE: PDCC) (the "Company") today announced that it has priced an underwritten public offering of 1,200,000 shares of its 8.00% Series A Preferred Stock Due 2029 (the "Preferred Shares") at a public offering price of $25 per share, which will result in net proceeds to the Company of approximately $28.8 million after payment of underwriting discounts and estimated offering expenses payable by the Company. The Preferred Shares are rated 'BBB' by Egan-Jones Ratings Company, an independent rating agency. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 180,000 Preferred Shares pursuant to the same terms and conditions. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. Top trending stories from the past week. News, Sports, and more throughout the week. The week's obituaries, delivered to your inbox.Week 12 has started with an upset. The Cleveland Browns prevailed over the Pittsburgh Steelers 24-19 on Thursday Night Football , surviving the elements of the first snow game of the 2024 season. Cleveland took a commanding 18-6 lead early in the fourth quarter with Pittsburgh unable to find offensive rhythm, but it came back to seize a 19-18 lead late on fueled by forcing turnovers in the weather. However, Jameis Winston responded with a late nine-play, 45-yard drive to give Cleveland the advantage again. Russell Wilson had the chance to reply one last time for the win, but the Browns swatted down his last-ditch Hail Mary attempt. The shock result moves Cleveland to 3-8, while Pittsburgh dropped to 8-3 in an AFC that is tight at the top. Let's analyze the game further with winners and losers: WINNER: Nick Chubb, Browns Chubb has been far from his best after returning from gruesome leg injuries sustained last season, but he played a pivotal role for Cleveland. The 28-year-old rushed for 59 yards on 20 carries for two touchdowns, including the eventual game winner. It was his first multi-rushing touchdown game since Halloween of 2022. Though this game may not spur Cleveland up the AFC ladder, it's a positive sign for Chubb to pick up individual momentum. LOSER: Steelers' offensive weapons The Steelers typically deploy a robust defense under Mike Tomlin, but the offensive talent around Wilson has been in question. Mike Williams was acquired at the deadline, but he's still yet to produce for any team this season and did not feature in this game. Wilson completed 21 of 28 passes for 270 yards, one touchdown and a pick, but the offense's inability to consistently move the chains in the first three quarters was evident. Pittsburgh's downfall in this game may have just foreshadowed how its season could end against stronger teams. WINNER: Snow games Cleveland hosted the first snow game of the season. While the temperature and field was just fine during the first half, the snow kicked it up a notch in the second. It predictably resulted in more drops by receivers and fumbles. The two teams combined for five fumbles, with three recovered by the opposition. Cleveland's fourth-quarter miscue could've been costly, but it held on for the victory. LOSER: Third-down disparity Most of the key team stats point to this being a game the Steelers let slip away. Specifically, the third-down disparity ended on a brutal note from Pittsburgh's point of view. Pittsburgh converted on a solid 7-for-16 third downs, and had more total yards, drives and possession time along with fewer penalties. Cleveland, on the other hand, converted on just 1-for-10 third downs. But it flipped the switch when it mattered the most, moving the chain on all four fourth-down attempts. Pittsburgh wasn't limited by the snow given how it managed to retake the lead during the pouring, but the statistics will definitely frustrate Mike Tomlin and Co. WINNER: Jerry Jeudy, Browns After a slow and poor first eight weeks of the season, Jeudy has found improved form with Winston as QB1. He ended the game with six catches on six targets for 85 yards, coming up big whenever the Browns needed him. It also marked four straight games of at least five or more catches for the 25-year-old. While that might not sound like a lot for the former first rounder, he logged three straight games of just one catch each from Weeks 5-7. Last time out against the Saints he recorded six catches on 11 targets for a season-high 142 yards and a score.
Tennis coach Judy Murray says those born male should only compete with men4,929 Shares in HF Sinclair Co. (NYSE:DINO) Acquired by Townsquare Capital LLCAnduril and Palantir to Accelerate AI Capabilities for National Security
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 12, 2024-- Takeda ( TSE:4502/NYSE:TAK ) will host an investor R&D Day today beginning at 8:30 a.m. JST in Tokyo. The meeting will focus on programs in the company’s late-stage pipeline, the transformative value they could deliver to patients, and the market opportunities they represent. “We are focused on advancing our innovative pipeline and accelerating late-stage programs to deliver sustainable revenue growth to 2030 and beyond, building upon the strong momentum of our Growth and Launch Products,” said Christophe Weber, Takeda chief executive officer. “The first three Phase 3 programs will read out in 2025, initiating a cadence of potential filings across multiple indications over the next several years.” Eight Regulatory Filings in FY2025 – FY2029 The late-stage pipeline includes oveporexton (TAK-861), zasocitinib (TAK-279), rusfertide (TAK-121), mezagitamab (TAK-079), fazirsiran (TAK-999) and elritercept (TAK-226). Combined these programs have potential peak revenue 1 of $10B - $20B. Data from three Phase 3 programs is expected to read out in 2025: Filings for these three indications are expected in fiscal years 2025 and 2026. Five additional indication filings for late-stage programs are on pace for fiscal years 2027 through 2029: “Takeda has established an exciting, late-stage pipeline of transformative therapies that we believe will deliver value to our company and, most importantly, to the patients we serve around the world,” said Andy Plump, president of R&D at Takeda. “As we continue scaling our capabilities and maximizing R&D investment to deliver the late-stage pipeline, we are also progressing an exciting early-stage pipeline, supporting a cutting-edge research organization, and focusing on creative business development across our therapeutic areas to sustain Takeda’s future and continue to meet significant unmet patient needs.” 2024 R&D Day Agenda The meeting includes the following presentations and speakers: A Global, Innovation-Driven Biopharmaceutical Company Christophe Weber, President & CEO R&D Strategy and Pipeline Highlights Andy Plump, President, Research and Development Neuroscience: Deep-Dive on Orexin Franchise Sarah Sheikh, Head of Neuroscience Therapeutic Area Unit and Head of Global Development Ramona Sequeira, President of Global Portfolio Division Gastrointestinal and Inflammation: Deep-Dive on Zasocitinib, Rusfertide, Mezagitamab, Fazirsiran Chinwe Ukomadu, Head of Gastrointestinal and Inflammation Therapeutic Area Unit Ramona Sequeira, President of Global Portfolio Division Oncology: Deep-Dive on Elritercept – Newly Announced Business Development Deal Teresa Bitetti, President Global Oncology Business Unit P.K. Morrow, Head of Oncology Therapeutic Area Unit Webcast Details A live webcast of the meeting begins at 8:30 a.m. JST December 13 (6:30 p.m. EST December 12). Presentations are available on the Investor Relations section of Takeda’s website where a video replay will be available following the meeting. About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com . Important Notice For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. Forward-Looking Statements This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings-and-security-reports/ or at www.sec.gov . Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results. Peak Sales and PTRS Estimates References in this press release to peak revenue potential ranges are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue potential ranges represent Takeda’s assessments of various possible future commercial scenarios that may or may not occur. References in this press release to PTRS are to internal estimates of Takeda regarding the likelihood of obtaining regulatory approval for a particular product in a particular indication. These estimates reflect the subjective judgment of responsible Takeda personnel and have been approved by Takeda’s Portfolio Review Committee for use in internal planning. Medical Information This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development. Elritercept license agreement Elritercept is included for reference only. Takeda entered into an exclusive license agreement with Keros for global rights, in all territories outside of mainland China, Hong Kong and Macau, to Elritercept. The closing of the transaction is subject to receipt of regulatory approval(s), expected in the first calendar quarter of 2025. Takeda does not currently have rights to Elritercept. ___________________________ 1 References in this presentation to peak revenue potential are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue ranges represent Takeda’s assessments of various possible future commercial scenarios that may or may not occur. View source version on businesswire.com : https://www.businesswire.com/news/home/20241211148492/en/ CONTACT: Investor Relations Christopher O’Reilly Christopher.oreilly@takeda.com +81 (0) 90-6481-3412 Takeda Media Relations media_relations@takeda.com KEYWORD: MASSACHUSETTS UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC INDUSTRY KEYWORD: ONCOLOGY HEALTH NEUROLOGY CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Takeda Pharmaceutical Company Limited Copyright Business Wire 2024. PUB: 12/12/2024 05:30 PM/DISC: 12/12/2024 05:30 PM http://www.businesswire.com/news/home/20241211148492/en
Seattle Seahawks receiver is DK Metcalf is just fine when he doesn't have the the ball because it means he gets to showcase his blocking skills. “I just look at it as a sign of respect that I’ve gained from other defensive coordinators and just continue to do my job with it as blocking or being a decoy,” the two-time Pro Bowler said. While opposing defenses have keyed in on Metcalf, other aspects of Seattle's offense have surfaced during its four-game winning streak. The run has the Seahawks (8-5) sitting atop the NFC West heading into Sunday night's game against the visiting Green Bay Packers (9-4). Geno Smith's new top target is second-year receiver Jaxon Smith-Njigba, who needs 89 receiving yards for his first career 1,000-yard season. Smith-Njigba has 75 catches for 911 yards and five touchdowns, while Metcalf, often dealing with double coverage, has 54 catches for 812 yards and two scores. Metcalf says he feels the pride of a “proud parent or a big brother” when it comes to Smith-Njigba's success. Seattle's offense also got a boost from the ground game in a 30-18 victory over the Arizona Cardinals last weekend . Zach Charbonnet, filling in for the injured Kenneth Walker III, ran for a career-best 134 yards and two touchdowns. The Seahawks face another hot team in the Packers (9-4), who have won seven of nine. Green Bay's two losses over that stretch have come against NFC-best Detroit (12-1), including a 34-31 victory by the Lions on Dec. 5, which means the NFC North title is likely out of reach for the Packers. The Packers are well-positioned for a playoff berth, but that almost certainly won't come this weekend. They would need a win, a loss or tie by the Atlanta Falcons and a tie between the Los Angeles Rams and San Francisco 49ers. Metcalf, who learned to block from his father, former Chicago Bears offensive lineman Terrence Metcalf, says he tries to take blocking seriously to set himself apart from other receivers. His priorities are simple when he's getting double-teamed and the ball goes elsewhere. “Trying to block my (butt) off and trying to get pancakes on defensive backs,” he said. When the Packers surged their way into the playoffs last season, quarterback Jordan Love was a major reason why. He had 18 touchdown passes and one interception during Green Bay's final eight games. During the last four games of this season, Love ranks third in the NFL with a 118.9 passer rating with six touchdowns, one interception and a league-best 10.3 yards per attempt. “I always feel like I can put the ball where I want to — and that’s part of it, too, having that confidence to be able to throw those passes,” Love said. “There’s always like I said a handful of plays that might not come off or be in the exact spot that you wanted it to or the throw might be a little bit off. So, that’s where you’ve just got to try to be at your best every play, be consistent and accurate as possible.” Green Bay’s pass defense has been picked apart the last two weeks. First, it was torched by Tua Tagovailoa and the Dolphins in a Packers win. Next, it allowed Jared Goff to complete his final 13 passes as the Lions rallied to victory. It won’t get any easier this week. Smith is second in the NFL in attempts, completions and passing yards and is fifth in completion percentage. “It’s been a remarkable turnaround for him in terms of just where he started,” Packers coach Matt LaFleur said. “It’s not always where you start, but where you finish. And it tells me a lot about the person in terms of his resiliency and ability to fight through some adversity. He’s a dangerous quarterback.” The potential return of former All-Pro cornerback Jaire Alexander (knee) could help the Packers. Will the Packers break out their head-to-toe white uniforms? The last time Green Bay wore the winter white look was in a 24-22 win over Houston in October. The Packers asked fans to weigh in on social media . As for the Seahawks, they'll be sporting their “Action Green” uniforms. Metcalf is a fan. “I would say this about the Action Green, I love them personally in my opinion, but the big guys hate them. I don’t know why, don’t ask me," he said. “Hopefully, the Packers wear all white, so it’ll be a fun-looking game.” AP NFL: https://apnews.com/hub/nflCNX Resources ( NYSE:CNX – Get Free Report ) had its price objective raised by Truist Financial from $34.00 to $35.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “hold” rating on the oil and gas producer’s stock. Truist Financial’s price target indicates a potential downside of 4.94% from the company’s previous close. Other equities research analysts have also issued research reports about the company. Tudor, Pickering, Holt & Co. lowered CNX Resources from a “hold” rating to a “sell” rating in a research report on Tuesday, October 1st. BMO Capital Markets raised their target price on shares of CNX Resources from $26.00 to $29.00 and gave the stock a “market perform” rating in a report on Friday, October 4th. Scotiabank increased their price objective on shares of CNX Resources from $25.00 to $27.00 and gave the stock a “sector underperform” rating in a research report on Tuesday, August 20th. Piper Sandler boosted their price objective on shares of CNX Resources from $20.00 to $23.00 and gave the company an “underweight” rating in a research report on Friday. Finally, Tudor Pickering upgraded CNX Resources to a “strong sell” rating in a report on Tuesday, October 1st. Seven research analysts have rated the stock with a sell rating and six have given a hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $30.00. View Our Latest Report on CNX Resources CNX Resources Stock Performance CNX Resources ( NYSE:CNX – Get Free Report ) last announced its quarterly earnings results on Thursday, October 24th. The oil and gas producer reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.32 by $0.09. CNX Resources had a net margin of 27.79% and a return on equity of 7.54%. The company had revenue of $424.21 million for the quarter, compared to analysts’ expectations of $398.33 million. During the same period last year, the firm posted $0.35 earnings per share. As a group, sell-side analysts forecast that CNX Resources will post 1.53 earnings per share for the current year. Insider Activity In related news, Director Bernard Lanigan, Jr. bought 75,000 shares of the business’s stock in a transaction dated Monday, September 9th. The stock was purchased at an average cost of $26.81 per share, for a total transaction of $2,010,750.00. Following the transaction, the director now owns 401,820 shares in the company, valued at $10,772,794.20. The trade was a 22.95 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink . 3.10% of the stock is owned by corporate insiders. Institutional Investors Weigh In On CNX Resources Institutional investors and hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC grew its holdings in CNX Resources by 54.1% during the 2nd quarter. GAMMA Investing LLC now owns 1,896 shares of the oil and gas producer’s stock worth $46,000 after acquiring an additional 666 shares during the period. Blue Trust Inc. grew its stake in CNX Resources by 135.4% during the third quarter. Blue Trust Inc. now owns 1,966 shares of the oil and gas producer’s stock worth $64,000 after purchasing an additional 1,131 shares during the period. CWM LLC increased its holdings in CNX Resources by 77.0% in the third quarter. CWM LLC now owns 2,149 shares of the oil and gas producer’s stock worth $70,000 after purchasing an additional 935 shares in the last quarter. Innealta Capital LLC acquired a new position in CNX Resources in the second quarter valued at approximately $131,000. Finally, Atomi Financial Group Inc. bought a new position in shares of CNX Resources during the 3rd quarter worth approximately $202,000. Institutional investors own 95.16% of the company’s stock. CNX Resources Company Profile ( Get Free Report ) CNX Resources Corporation, an independent natural gas and midstream company, engages in the acquisition, exploration, development, and production of natural gas properties in the Appalachian Basin. The company operates in two segments, Shale and Coalbed Methane (CBM). It produces and sells pipeline quality natural gas primarily for gas wholesalers. Featured Articles Receive News & Ratings for CNX Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNX Resources and related companies with MarketBeat.com's FREE daily email newsletter .
Pearl Diver Credit Company Inc. Prices Offering of Series A Preferred Stock
Photo courtesy of Jingo SAN FRANCISCO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Jingo, a new artificial intelligence (AI)-driven e-commerce marketplace , unveiled the launch of its anticipated referral program. This strategic initiative aims to accelerate user growth while rewarding loyal customers with substantial shopping credits. The program, running from December 6, 2024, to February 28, 2025, offers participants the chance to win significant prizes for successfully referring new users to the platform. The top referrer will receive an impressive $50,000 in shopping credits, while the second and third-place winners will be awarded $30,000 and $10,000 in credits, respectively. Jingo has garnered attention for its personalized shopping experiences, driven by innovative AI technology. The referral program represents a key milestone in the platform's journey toward transforming e-commerce. Rohan Bhanot, co-founder of Jingo, expressed enthusiasm about the program: " We are thrilled to launch this referral campaign as a way to thank our early adopters and encourage them to share the Jingo experience with friends and family. This program aligns perfectly with our goal to create a community-driven marketplace that understands and anticipates user needs." The platform has secured backing and investment from industry leaders with extensive experience at companies like Pinterest, Walmart, Minted, eBay, and other prominent technology and retail organizations. "We are so excited to have such an accomplished group of investors backing our goal. Their collective experience across technology, retail, and e-commerce will be invaluable as we work to change the online shopping experience," shares Ujjal Pathak, co-founder and chief executive officer (CEO) of Jingo. Program participation is straightforward: existing users share their unique referral code with potential new users. When referred individuals complete their first purchase, referrers earn credit toward the program's substantial prizes. The initiative welcomes participation from all users across the United States, with no state restrictions. "This referral campaign will drive user growth and improve the overall Jingo experience. As our user base expands, Buddy becomes even more intelligent and capable of providing hyper-personalized recommendations," adds Pathak. For more information about Jingo and its referral program, visit www.jingo.app . About Jingo Jingo is an innovative e-commerce platform transforming shopping into a hyper-personalized experience tailored to individual preferences. By leveraging advanced AI and data-driven insights, Jingo delivers product recommendations that align seamlessly with each user's unique tastes and needs. The company's mission is to make shopping a proactive and intuitive experience, fundamentally changing how people engage with commerce and technology. Jingo is supported by experts with deep experience across leading companies such as Pinterest, Walmart, Minted, eBay, Square, Nike, Klarna, and Intuit. This collective expertise drives its vision to set a new standard for personalization, connecting customers with the products they love while creating a smarter, more efficient shopping ecosystem. Contact information: Name: Ujjal Pathak Email: ujjal@jingo.app Company: Jingo Technologies Website: www.jingo.app A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f3cada3e-418b-4133-9ce0-5e74219a7443 © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Upcoming IPOs: Vishal Mega Mart, One Mobikwik, And Sai Life Sciences Set To Hit The Market - Key Details
WASHINGTON , Dec. 6, 2024 /PRNewswire/ -- NASA has selected Nova Space Solutions, LLC of Anchorage, Alaska , to provide operations, services, maintenance, and infrastructure support for NASA's Stennis Space Center near Bay St. Louis, Mississippi , and NASA's Michoud Assembly Facility in New Orleans . The Combined Operations, Services, Maintenance, and Infrastructure Contract is a cost-plus-incentive-fee, firm-fixed-price, and indefinite-delivery/indefinite-quantity contract that has a value of approximately $822.7 million . The performance period begins July 1, 2025 , and extends eight years and three months, with a 15-month base period, followed by a one-year option period and three two-year option periods. Under the contract, Nova Space Solutions will be responsible for contract management, logistics, safety, health and environmental compliance, engineering and manufacturing support services, site services, facility operations and maintenance services, and environmental services and program management. NASA's Stennis Space Center is the nation's largest propulsion test site, with infrastructure to support projects ranging from component and subscale testing to large engine hot fires. Researchers from NASA, other government agencies, and private industry use NASA Stennis test facilities for technology and propulsion research and developmental projects. NASA's Michoud Assembly Facility, managed by the agency's Marshall Flight Center in Huntsville, Alabama , is the nation's premier site for manufacturing and assembly of large-scale space structures and systems. For information about NASA and other agency programs, visit: https://www.nasa.gov View original content to download multimedia: https://www.prnewswire.com/news-releases/nasa-awards-operations-services-maintenance-and-infrastructure-contract-302325313.html SOURCE NASAPHILADELPHIA -- running back set a franchise record for single-season rushing yards Sunday in a 22-16 victory over the . Barkley entered the day needing 109 yards to move past , who rushed for 1,607 yards in 2013. He moved into first place midway through the fourth quarter with a 9-yard gain. Chants of "MVP!" broke out as his achievement was announced in the stadium. He finished the game with 124 yards rushing. "That's something, once I got here, I looked up the history of the Eagles' running backs," Barkley said this week. "That's your goal, you want to come in here and leave a legacy on a place, on a franchise. I had the same mindset when I was in New York. Sadly, that came up short. "I'm aware of [the record] but it's not the driving factor: the driving factor is to win football games and put ourselves in position to make a run and go win it all. But I am aware of the things I can accomplish. But the way I accomplish that is by sticking to the script." Barkley is enjoying a career year in his first season in Philadelphia. He needed just 12 games to set a personal best in single-season rushing yards, and established new highs in single-game rushing yards (255) and yards from scrimmage (302) in Week 12 against the . Barkley was named NFC Offensive Player of the Month for November -- the first of his career. He has four NFC Player of the Week honors this season, one more than he had during his entire six-year stint with the Giants. He entered Sunday ranked No. 1 in rushing yards (1,499) in the NFL.
Ammu R., who has been running a fruit shop on South Mada Street at Mylapore, eagerly awaits the Margazhi season more than any other. It is because during this time her stall gets a makeover, glowing brighter with colours of rangoli and kolam powders. “The rangoli powder will always be in stock at my shop, but the demand soars during Margazhi. We sell each box for ₹20,” says Ms. Ammu. Steady business She says the demand for the kolam colours has never waned, and year after year, the customers come steady. “A regular customer bought rangoli powders for ₹500,” she says, beaming. As she chats, more customers stream in, stacking their bags with boxes of the season’s must-have colours. “People from all over Chennai flock to Mylapore for the colours because there is usually a spot where there is a box of every shade possible,” Ms. Ammu says. “And it is not just locals. We see visitors from abroad curious about kolam powders and the rangoli colours,” she adds. A row of shops along the Mada Streets is brimming with hues and shades of kolam powders, a staple of the Margazhi season. On the corner of North Mada Street is R. Devi with her family; they juggle everything, from stringing flowers to selling sugar cane and small diyas throughout the year. But when it is December, the family mainly sells kolam powders, bringing large sacks from various markets in and around Chennai. Many tasks “I am usually up at 3 a.m., heading to the Koyambedu market for buying fresh flowers. After selling the flowers, I am already setting up kolam powders by noon,” says Devi, expertly scooping powder into smaller boxes from the sack. She is adept at putting up these different small stalls one after the other with the changing seasons. This has not only helped to build a loyal customer base but has also funded her children’s education. “My daughters and son are in good schools and colleges because of my working day and night,” she says. Her daughter, R. Sangeetha, who graduated recently with a degree in economics, pitches in while job-hunting. “My mother has been at this very spot for decades, like my grandmother. But my family wishes a big career for me,” she says. On the same street, Surekha S. from Pattinapakkam is equally busy, juggling flower garlands and rangoli powders, along with her mother. “Not only the classic reds and blues that are flying off the shelves, grey and not so primary colours are also becoming popular,” she says. Rain, a spoiler Surekha admits that rain sometimes impacts their stock, making the colours hard to come on those days. “This is the season we usually look out for, and from these sales, we save up for leaner months,” she says. Despite selling rangoli powders every year, Surekha chuckles that she is only a beginner, learning to join the dots of kolam through YouTube. “Kolam and rangoli are not just decoration. They are an art form and not as easy as they look,” she says. Published - December 24, 2024 11:02 pm IST Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp RedditNew York Emerging Technology Advisory Board Publishes First Report Outlining Vision to Elevate Leadership in AIMumbai: Aaditya Thackeray's shows door to Siddique's son Zeeshan Siddique in Bandra East
Thankfully, the field for the inaugural 12-team College Football Playoff was set Sunday morning. Had the process lasted another week, it might have ripped the sport apart and pitted conference commissioners against each other in steel-cage matches. Not everything sparked outrage when the CFP selection committee revealed the pairings. Oregon and Georgia were the top-two seeds, as expected. Boise State, champion of the Mountain West, and Arizona State, which won the Big 12, received the No. 3 and 4 seeds, respectively, and will have opening-round byes. Texas, Penn State, Notre Dame and Ohio State will play home games in the opening round. But that’s where the relative peace and tranquility ended. The committee granted the final at-large berth to SMU, not Alabama, and you could instantly imagine smoke billowing from the nostrils of SEC commissioner Greg Sankey. Alabama (9-3) had more quality wins and played a vastly tougher schedule than the Mustangs (11-2) but also had uglier losses than the ACC runner-up. That wasn’t the only flashpoint. Boise State was seeded higher than Arizona State despite a weaker schedule — an outcome that sends the Broncos to the Fiesta Bowl (Glendale) for their quarterfinal game and forces the Sun Devils to play in the Peach Bowl (Atlanta). The debate Sunday was simply a continuation of the past five weeks, which featured athletic directors squabbling on social media, conference commissioners squawking over resumes and the committee chair himself, Michigan athletic director Warde Manuel, seemingly contradicting the stated selection criteria. All of it unfolded under the threat of demolition. Two months ago, executives from the SEC and Big Ten gathered in Nashville to discuss the future of the sport. At the conclusion of the summit, Sankey, the most powerful figure in the sport, told reporters that the CFP process “just has to go incredibly well.” You did not need a master’s degree in political gamesmanship to grasp the meaning. If the SEC and Big Ten were less than satisfied with their allotments of bids and seeds, they would force changes to the selection process. Specifically, the behemoths would grant themselves a truckload of automatic bids, reduce access for the other conferences and, potentially, disband the selection committee altogether. Needless to say, the process did not go “incredibly well” for the SEC. In fact, it could not have gone much worse. In addition to Alabama’s exclusion, Tennessee lost the No. 8-9 seed showdown against Ohio State and will open the playoff in Columbus. Meanwhile, three-loss South Carolina was left out entirely one week after winning at three-loss Clemson, while the Tigers advanced to the CFP with the ACC’s automatic bid. (In the committee’s final rankings, South Carolina was one spot above Clemson.) The repercussions could ripple through the sport for years. Earlier this week, another warning flare went skyward from SEC country when Alabama athletic director Greg Byrne posted the following note on the social media platform X: “When you look at the @CFBPlayoff Principles for its Selection Committee, the first bullet point on the list of considerations is strength of schedule. Not all schedules and conferences are created equal. We’ve worked diligently to add more challenging non-conference home-and-homes, which is good for college football ...” The implication was clear: If Alabama’s schedule strength wasn’t rewarded, the Crimson Tide would rethink the merits of playing A-level non-conference games in the first half of September. Alabama faced Wisconsin this season and has booked upcoming series with Florida State, Ohio State and Notre Dame. Those could be in jeopardy. Why risk the loss when the benefits of scheduling the game are limited? And if Alabama cancels marquee matchups, other SEC schools will assuredly follow — potentially sapping the sport of must-see intersectional duels that energize the September competition calendar. Asked on ESPN about the non-conference scheduling issue, Manuel, the committee chair and Michigan’s athletic director, offered the following: “I would just say, you need to schedule the games you feel are best for your team and your fan base.” Given the unprecedented nature of the season — with the expanded playoff and engorged conferences — there was no reason to expect a smooth ride from early November, when the first CFP rankings were released, through selection day. But the gaffes, misreads and contradictions by the 13-person committee were frequent and severe. Head-to-head results, schedule strength and quality wins were shoved to the background as the committee, loaded with former coaches, prioritized win-loss record. It was as if the coaches were collectively channeling their inner Lou Holtz — the former Notre Dame coach was the ultimate sandbagger — and determined a 74- point win over Western Illinois (by Indiana) was equivalent to a 15-point win at Texas (by Georgia). “One of the things we really need to do,” said Nick Saban, the ESPN analyst and former Alabama coach, “is (recognize) all wins are not the same as the other wins.” There were risks to selecting Alabama over SMU, as well. Had the committee excluded the Mustangs following their loss to Clemson in the ACC championship — on a walk-off field goal, no less — the decision would have undermined the credibility of conference title games. “The committee is going to lose no matter what they do,” ESPN analyst Kirk Herbstreit said. But just as not all wins are created equal, neither are all losses. Alabama’s out, the SEC is seething and major changes are coming to the CFP as a result. *** Send suggestions, comments and tips (confidentiality guaranteed) to wilnerhotline@bayareanewsgroup.com or call 408-920-5716 *** Follow me on the social media platform X: @ WilnerHotline